Patrizia Nanni
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody.
Journal: NPJ vaccines
Published: September 11, 2025
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture.
Journal: Biological research
Published: August 19, 2025
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response.
Journal: Frontiers in pharmacology
Published: July 29, 2025
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.
Journal: Journal of translational medicine
Published: December 03, 2024
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay.
Journal: Methods in cell biology
Published: November 08, 2024
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
Journal: Cell communication and signaling : CCS
Published: August 18, 2024
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Journal: International journal of molecular sciences
Published: July 31, 2023
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC.
Journal: Translational lung cancer research
Published: March 02, 2022
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.
Journal: Cells
Published: June 07, 2021
Last Updated: 09/26/2026